Evidence map›Paper›PMID 42756787›Full record

ArticleChina CDC weekly2026

Pilot Surveillance Program on Pneumonia with Public Health Risk - Shanghai Municipality, China, 2024-2025.

Qiwen Fang, Xiaohuan Gong, Shenghua Mao, Dongsheng Ren, Hongyou Chen, Miao Pan, Xiaoyan Huang, Jian Chen, Xin Chen, Huanyu Wu and 1 more

Abstract read
In one paragraph

Article in China CDC weekly, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Qiwen FangShanghai Municipal Center for Disease Control and Prevention (Shanghai Academy of Preventive Medicine), Shanghai, China.
Xiaohuan GongShanghai Municipal Center for Disease Control and Prevention (Shanghai Academy of Preventive Medicine), Shanghai, China.
Shenghua MaoShanghai Municipal Center for Disease Control and Prevention (Shanghai Academy of Preventive Medicine), Shanghai, China.
Dongsheng RenShanghai Jing'an District Center for Disease Control and Prevention (Shanghai Jing'an District Health Supervision Institute), Shanghai, China.
Hongyou ChenShanghai Municipal Center for Disease Control and Prevention (Shanghai Academy of Preventive Medicine), Shanghai, China.
Miao PanShanghai Municipal Center for Disease Control and Prevention (Shanghai Academy of Preventive Medicine), Shanghai, China.
Xiaoyan HuangShanghai Municipal Center for Disease Control and Prevention (Shanghai Academy of Preventive Medicine), Shanghai, China.
Jian ChenShanghai Municipal Center for Disease Control and Prevention (Shanghai Academy of Preventive Medicine), Shanghai, China.
Xin ChenShanghai Municipal Center for Disease Control and Prevention (Shanghai Academy of Preventive Medicine), Shanghai, China.
Huanyu WuShanghai Municipal Center for Disease Control and Prevention (Shanghai Academy of Preventive Medicine), Shanghai, China.
Yaxu ZhengShanghai Municipal Center for Disease Control and Prevention (Shanghai Academy of Preventive Medicine), Shanghai, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

What is already known about this topic?: China's surveillance for pneumonia of unknown etiology, established in 2004, is vital for identifying novel pathogens early. However, limited cases have been reported, indicating potential challenges regarding sensitivity and operational efficiency. What is added by this report?: A pilot surveillance program to detect pneumonia with public health risk was implemented in Shanghai between October 2024 and July 2025. The system was established using an optimized workflow involving refined case definitions, tiered laboratory testing network, and joint expert risk assessment process. Forty-six cases were identified in medical institutions at different levels, demonstrating the system's operational feasibility. What are the implications for public health practice?: The pilot provides a framework for a proactive paradigm for monitoring emerging respiratory threats. Future surveillance should prioritize identifying case clusters and specific epidemiological links (e.g., suspicious animal contact and travel history). Applying advanced diagnostics, including metagenomic sequencing, and integrating multi-source data with information technology are crucial next steps for building a more responsive surveillance system.

Indexed as

Early warningEmerging respiratory infectious diseasesPneumonia surveillancePublic health risk

Identifiers

PMID42756787
PMCPMC13583503

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.